JNJ vs DVA
By Alex · Tickerpine
Johnson & Johnson vs DaVita Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | DVA |
|---|---|---|
| Price | $285.75 | $174.56 |
| Market cap | $687.89B | $10.98B |
| P/E ratio | 43.4 | 13.2 |
| ROE | 20.02% | 96.79% |
| Profit margin | 16.20% | 6.49% |
| Revenue growth | 5.90% | 4.60% |
| Dividend yield | 1.88% | 0.00% |
| Beta | 0.20 | 0.86 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs DVA in plain English
- JNJ is the bigger company — about 62.7× the market cap of DVA.
- DVA is cheaper on earnings (P/E 13.2 vs 43.4).
- DVA earns a higher return on equity (97% vs 20%).
- JNJ is growing revenue faster (6% vs 5%).
- JNJ pays a dividend (1.88%) while the other effectively doesn't.
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
DVA return calculator
See what $1,000 in DaVita Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.